Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.

× No keyword cloud information.

9 in total

Review 1. Recent developments for Pseudomonas vaccines.

Authors: Anurag Sharma; Anja Krause; Stefan Worgall
Journal: Hum Vaccin Date: 2011-10-01

2. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.

Authors: G B Pier; S E Bennett
Journal: J Clin Invest Date: 1986-02 Impact factor: 14.808

3. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors: G B Pier; H F Sidberry; J C Sadoff
Journal: Infect Immun Date: 1978-12 Impact factor: 3.441

4. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.

Authors: M R Moody; R W Kessel; V M Young; P Fiset
Journal: Infect Immun Date: 1978-09 Impact factor: 3.441

5. A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa.

Authors: Mohammad Reza Rahbar; Shaden M H Mubarak; Anahita Hessami; Bahman Khalesi; Navid Pourzardosht; Saeed Khalili; Kobra Ahmadi Zanoos; Abolfazl Jahangiri
Journal: Sci Rep Date: 2022-06-27 Impact factor: 4.996

6. Structural elucidation of the lipopolysaccharide core region of the O-chain-deficient mutant strain A28 from Pseudomonas aeruginosa serotype 06 (International Antigenic Typing Scheme).

Authors: H Masoud; I Sadovskaya; T de Kievit; E Altman; J C Richards; J S Lam
Journal: J Bacteriol Date: 1995-12 Impact factor: 3.490

Preliminary investigations of Pseudomonas aeruginosa vaccine in patients with leukemia and cystic fibrosis.

Review 1. Recent developments for Pseudomonas vaccines.

2. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.

3. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

4. Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.

5. A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa.

6. Structural elucidation of the lipopolysaccharide core region of the O-chain-deficient mutant strain A28 from Pseudomonas aeruginosa serotype 06 (International Antigenic Typing Scheme).

7. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.

Review 8. Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Review 9. Pseudomonas aeruginosa: Recent Advances in Vaccine Development.